Citation: Re. See et al., Dopamine, but not glutamate, receptor blockade in the basolateral amygdalaattenuates conditioned reward in a rat model of relapse to cocaine-seekingbehavior, PSYCHOPHAR, 154(3), 2001, pp. 301-310
Citation: Re. See et Wj. Berglind, Decreased pallidal GABA following reverse microdialysis with, clozapine, but not haloperidol, NEUROREPORT, 12(17), 2001, pp. 3655-3658
Citation: Jw. Grimm et al., Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats, SYNAPSE, 39(1), 2001, pp. 51-57
Citation: Pj. Kruzich et al., Conditioned reinstatement of drug-seeking behavior with a discrete compound stimulus classically conditioned with intravenous cocaine, BEHAV NEURO, 115(5), 2001, pp. 1086-1092
Citation: Pj. Kruzich et Re. See, Differential contributions of the basolateral and central amygdala in the acquisition and expression of conditioned relapse to cocaine-seeking behavior, J NEUROSC, 21(14), 2001, pp. NIL_16-NIL_20
Citation: Jw. Grimm et Re. See, Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse, NEUROPSYCH, 22(5), 2000, pp. 473-479
Citation: Jw. Grimm et al., Contingent access to stimuli associated with cocaine self-administration is required for reinstatement of drug-seeking behavior, PSYCHOBIOLO, 28(3), 2000, pp. 383-386
Citation: Jw. Grimm et Re. See, Chronic haloperidol-induced alterations in pallidal GABA and striatal D-1-mediated dopamine turnover as measured by dual probe microdialysis in rats, NEUROSCIENC, 100(3), 2000, pp. 507-514
Citation: Pj. Kruzich et Re. See, An evaluation of the role of 5-MT2 receptor antagonism during subchronic antipsychotic drug administration in rats, BRAIN RES, 875(1-2), 2000, pp. 35-43
Citation: Re. See et al., The importance of a compound stimulus in conditioned drug-seeking behaviorfollowing one week of extinction from self-administered cocaine in rats, DRUG AL DEP, 57(1), 1999, pp. 41-49
Authors:
See, RE
Fido, AA
Maurice, M
Ibrahim, MM
Salama, GMS
Citation: Re. See et al., Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia, BIOL PSYCHI, 45(12), 1999, pp. 1653-1656